Literature DB >> 19962351

The most severe forms of type I autoimmune hepatitis are associated with genetically determined levels of TGF-beta1.

Natalia Paladino1, Ana Claudia Flores, Hugo Fainboim, Teresa Schroder, Miriam Cuarterolo, Carol Lezama, Esteban Gonzáles Ballerga, Diana Levi, Hugo Tanno, Gabriel Costanzo, Lourdes Arruvito, Leonardo Fainboim.   

Abstract

We previously reported that paediatric (PAH) and adult (AAH) forms of type I autoimmune hepatitis (AH) have different HLA-associations and clinical outcome. In the present study we investigated the role of TGF-beta1 genetic polymorphisms in the different outcome of PAH and AAH. We found a significant increase of "high producer" 25GG genotype in PAH and 10CC in AAH. Low inflammation and low fibrosis in AAH was associated with the increase of codon 10CC (high producer) and codon 25CC (low producer) genotypes. The analysis in AAH of the two positions-haplotypes revealed that combined presence of 25GG and 10CC seems to neutralize the 10CC effect which remained in AAH having the 10CC(+)-25GG(-) haplotype. Altogether these results may explain, at least partially, the different clinical outcome of AAH and PAH. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962351     DOI: 10.1016/j.clim.2009.11.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

Review 1.  Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors:  Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

Review 2.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

Review 3.  Autoimmune hepatitis in childhood: the role of genetic and immune factors.

Authors:  Priscila Menezes Ferri Liu; Débora Marques de Miranda; Eleonora Druve Tavares Fagundes; Alexandre Rodrigues Ferreira; Ana Cristina Simões e Silva
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

4.  Genetic background of autoimmune hepatitis in Japan.

Authors:  Kaname Yoshizawa; Takeji Umemura; Masao Ota
Journal:  J Gastroenterol       Date:  2010-10-19       Impact factor: 7.527

Review 5.  Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2021-04-09       Impact factor: 3.199

Review 6.  Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

Review 7.  Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response.

Authors:  Takashi Higuchi; Shomi Oka; Hiroshi Furukawa; Shigeto Tohma; Hiroshi Yatsuhashi; Kiyoshi Migita
Journal:  Hum Genomics       Date:  2021-01-28       Impact factor: 4.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.